H.E. Dr. Tawfiq Al Rabiah, Minister of Health was appointed in 2016 because of his exemplary qualifications and credentials. Prior to his current position, he was the former Saudi Minister of Commerce and Industry. He was also a highly respected mentor at the University of Pittsburgh. Dr. Al Rabia expanded his teaching capability by working as a faculty member at King Saud University. He was also the past Director General of the Information and Communications Technology sector at the Saudi Arabian General Investment Authority (SAGIA). In 2007, Dr. Al Rabiah was appointed as the Director General of the Saudi Industrial Property Authority (MODON).
Additionally, he became an Acting Deputy Minister of Commerce and Industry and the Supervisor for National Industrial Strategy Institution from April 2010 to January 2012. He has successfully implemented the concept of industrial estates and technology zones, knowing that he was actively involved in the establishments of the said zones in different cities of Saudi Arabia.
Prior to Dr. Tawfiq bin Fawzan Al Rabiah's designation as Minister of Health, King Salman bin Abdulaziz Al Saud meticulously and intensively made a review on the qualifications and suitability of Dr. Al Rabiah before finally declaring his well-deserved appointment.
H.E. Dr. Al Qasem Al Qasabi received his Bachelors Degree in Medicine & Surgery with 2nd degree honors from the Medical College King Saud University, Riyadh and finished his internship in 1978.
In 1995 he became a Fellow of the American College of Surgeons.
In 2000 he was appointed as Deputy Minister of Health for Executive Affairs; he was Chairman of the Rift Valley Fever committee and some of the Hajj Pilgrims committees. He was Chairman of the Board of Directors for two of the largest hospitals in the Kingdom and headed international Saudi delegations. He is a member of numerous councils including the Saudi Commission for Health Specialties and the Saudi Council for Health Services. In 2004 he was appointed by a Royal Decree as the Deputy Chief Executive Director of the King Faisal Specialist Hospital & Research Center in Riyadh and in 2005 he was appointed as Chief Executive Director of the King Faisal Specialist Hospital & Research Center and General Secretary and Member of the Board of Directors.
In 2009 he was promoted by a Royal Decree as the Chief Executive Officer at King Faisal Specialist Hospital & Research Center with excellency ranking which he has occupied until the present time.
He has a number of publications in the area of laparoscopic surgery and trauma as well as being a reviewer and member of the Editorial Board for a number of medical journals. He has been active in the area of academic medicine as a teacher and program director. His administrative experience ranges from governmental policy-making to practicing academic medicine as a Consultant and Senior Physician.
He is a member of numerous governmental committees in the healthcare sector,
some of which are ministerial committees that steers health strategies and
Currently he oversees specialized hospital practice and services as well as advanced research activities relating to basic as well as translational research and also the formulation of a biotechnology platform in Saudi Arabia. He also oversees academic training programs both at the undergraduate and graduate level and is a member of the Al Faisal University Board of Trustees. He is also a member of the Board of Directors of Prince Salman Centre for Disability Research.
Dr. Sultan T. Al-Sedairy, PhD currently holds the position of Executive Director, Research Centre at King Faisal Specialist Hospital & Research Centre (KFSH&RC). In addition to this responsibility, he is also an Adjunct Professor in the College of Medicine at Alfaisal University, Riyadh and an Advisor at King Abdulaziz City for Science and Technology.
Dr. Sultan Al-Sedairy graduated from the University of Puget Sound, Washington with a Bachelor of Science degree in Biology/Chemistry in 1979 after which he received his Medical Technology diploma from Cleveland Clinic, Ohio in 1981. Columbia University, New York, USA was his graduate school where he achieved his MA in Pathobiology (1982), continued with his MPhil in Pathobiology (1984) and gained his PhD in Pathobiology (Immunology) in 1987.
Dr. Al-Sedairy’s research interest is in immunology and he has authored or co-authored over 150 full- length papers and meeting abstracts.
He is a member of many professional societies and he holds membership in a number of high level committees locally which include Board of Directors, King Abdulaziz City for Science and Technology (KACST), Board of Trustees, King Salman Center for Disability Research, Oversight Committee for the National Strategy for Science and Technology and Innovation, College of Medicine Board of AlFaisal University, Technology Advisory Council of Saudi Technology Development and Investment Company (TAQNIA); and internationally including the Board of Trustees and Scientific Advisory Council of Dubai Harvard Foundation for Medical Research, Governing Council of International Network for Cancer Treatment and Research (INCTR), Executive and Scientific Committees of International Cancer Genome Consortium (ICGC), Advisory Board, KACST-UCSD Joint Center for Excellence in Nanomedicine and Engineering, Executive Committee of International Rare Diseases Research Consortium (IRDiRC), Technology Advisory Council of Saudi Technology Development and Investment Company (TAQNIA) Board of Directors International.
Prior to joining the Epidemic Intelligence Service (EIS) and serving the 2-year EIS residency in New Orleans, LA, Dr. McNabb worked for 13 years at the Oklahoma State Health Department. Since 1993, most of his professional efforts have focused on serving those in underdeveloped, underserved global settings. Before retirement from CDC in 2010, he was Associate Director for Science; Public Health Informatics and Technology Program Office; Office for Surveillance, Epidemiology, and Laboratory Services. From 2006 – 2008, he directed the Division of Integrated Surveillance Systems and Services, National Center for Public Health Informatics, CDC. He is now Research Professor and Director of the King Abdullah Fellowship Program (http://kingabdullahfellowship.com) at Emory University, Rollins School of Public Health. He also holds an appointment as Adjunct Professor, Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia. Teaching two classes at Rollins, GH 504 Effective Oral Communication and GH 592 Successful Scientific Writing. He also directs the Research Skills Development Course (www.researchskillsdevelopment.com) and Case Study Design and Development (www.casestudy.com). He teaches Effective Oral Communication in short-course format at the University of Michigan, Graduate Summer Session in Epidemiology (https://sph.umich.edu/gss) and Transforming Public Health Surveillance at Epidemiology and Population Health Summer Institute at Columbia University (https://cuepisummer.org). Having mentored 29 students through their M.P.H. or Ph.D., plus 14 fellows through the CDC Public Health Prevention Specialists program, he is jointly appointed in the Hubert Department of Global Health and the Department of Epidemiology. Promoted to Distinguished Consultant in 2005 and nominated for the 2005 CDC Charles C. Shepard Award, he completed the 2004 Senior Executive Services (SES) candidate development program and is certified by the Office of Personnel Management. Dr. McNabb serves on the Editorial Board, Epidemiology and Global Health and in private practice as Managing Partner, Public Health Practice, LLC (http://www.publichealthpractice.com).
Dr. Sulieman Nasser Al-Shehri is a consultant of public health and pediatrics and working as the Director General for School Health in Kingdom of Saudi Arabia. He conducts school health promotion to improve child and adolescent health in Saudi Arabia and the Arab Gulf nations, Dr. Sulieman has held many positions in the Ministry of Health (MOH) and Ministry of Education (MOE). He was the founder and manager of the National Maternal and Child Health (MCH) Program; trainer and supervisor for the Primary Health Care Programme at MOH; the National coordinator for Diarrhea Control Program; a co-investigator in several research projects with teams from King Saud University, King Faisal Specialists Hospital, King Saud University for Health Sciences, Ministry of Health and other health sectors. He is an active member in more than 35 associations and national committees. He is WHO temporary advisor (the Eastern Mediterranean region office EMRO, Cairo) in several meetings and conferences, round table discussions about "Promotion of Adolescent Health and Development in the Eastern Mediterranean Region "( Bahrian); the training course about "Health Promoting Schools Initiative," ( Muscat, Oman) , the inter-country consultation about "Adolescent Reproductive Health Promotion in the Eastern Mediterranean Region" (Cairo); "Building Abilities for Adolescent Health …. Prevention, Promotion and Development at the East Mediterranean Region, “ Hammamat city ( Tunisia ); the "Inter-country consultation for the methods of lowering underweight rate in neonates," held in Morocco, consultation on developing updated criteria and executive framework for health promoting schools in the Eastern Mediterranean Region, Cairo. He is a reviewer for several scientific medical journals: the Eastern Mediterranean Health Journal, issued by WHO: the "Saudi Journal of Family and Community Medicine," issued by Faculty of Medicine of Dammam; Annals of Saudi Medicine issued by King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, and several protocols presented to King Abdul Aziz City for Sciences and Technology for support in the fields of child, adolescents and maternity health.
He wrote more than 55 scientific publications about the school health strategies and policies, school health programs, health promotion, adolescent health and mental health in school settings.
Mr. Dusty Majumdar joined IBM Watson Health team as Vice President and Chief Marketing Officer. With 20 years of strong marketing and leadership experience at GE, Mr. Majumdar leads all marketing teams at Watson Health and is focused on driving marketing excellence across the organization, building robust go-to-market strategies, collaborating with Offering Management building strategic marketing plans and enabling the commercial teams with value added selling tools.
Mr. Majumdar has deep domain expertise and experience in healthcare in leading on all aspects of marketing ranging from strategic marketing to go-to-market execution working in companies like GE Healthcare and more recently, a diagnostic start-up (Exact Sciences). In the last start-up, he managed strategy, marketing and investor Day/Board presentations as the Head of Strategy/Marketing partnering with the CEO for DNA based early cancer screening solutions for GI, lung and pancreatic cancer based on next generation sequencing (NGS) leveraging cancer DNA detection with liquid biopsies via blood. At GE Healthcare, Mr. Majumdar led the marketing and branding for some of the most iconic imaging scanners (CT) launches for nearly a decade which led to dramatic improvement in diagnostic confidence and lowering of radiation dose for patients, positioning GE as the preeminent vendor in the space across all segments. Some of the leadership products Mr. Majumdar launched during his tenure at GE Healthcare include the Discovery, Optima and Revolution family of scanners. He also led the Digital Services marketing team for diagnostic imaging across GE Healthcare introducing several new solutions for proactive/predictive services during his tenure which resulted in GE taking #1 position in proving solutions and services to hospitals and out-patient imaging centers worldwide.
Prior to joining GE, Mr. Majumdar worked at the 3M Corporation at their R&D Division. He has over 25 U.S. Patents and 30+ peer reviewed publications across imaging, nanomaterials, health economics and self-assembly in soft polymeric materials. He holds a PhD from the University of Texas at Austin and a Bachelors degree from the Indian Institute of Technology. He and his wife recently moved to Boston, MA with their two children.
Mr. Guy Mansueto isVice President, Portfolio Marketing for IBM Watson Health. He is responsible for leading the development and implementation of go-to-market strategies and marketing for IBM Watson Health value-based care business unit. With over 25 years in the healthcare IT industry, Mr. Mansueto brings expertise in developing, marketing and delivering emerging technology solutions for the healthcare market.
Mr. Mansueto is on the Executive Committee of the Patient Centered Primary Care Collaborative (PCPCC), a coalition of major employers, consumer groups, patient quality organizations, health plans, labor unions, hospitals, and physicians who have joined together to develop and advance the patient centered medical home. He is on the Executive Steering Committee for the AMGF Measure Up/Pressure Down™ campaign; the advisory board for the University of Utah’s Institute of Healthcare Transformation; and, is the past president of the North / Central Florida Chapter HIMSS association.
Mr. Mansueto holds a Masters of Management degree from North Park University Business School in Chicago and a Bachelor of Science degree in Mathematics and Statistics from the Loyola University in Chicago.
Mr. Dennis L. Kogod is the CEO Emeritus of DaVita International. In this role, Mr. Kogod led the organization into 11 countries outside of the United States, including Germany, Colombia, Brazil, China, India, Malaysia and Saudi Arabia. During this same time, Mr. Kogod also held the title of president of HealthCare Partners, a DaVita Medical Group. Prior to this, he served as COO for HealthCare Partners and COO and group president for DaVita Kidney Care.
Before DaVita, Mr. Kogod served as president of the West Division for Gambro Healthcare and division president of Teleflex Medical Group, a global medical supplier. Mr. Kogod has a deep commitment to service and volunteerism, and established Bridge of Life - DaVita Medical Missions, a not-for-profit organization that has completed 30 missions to serve those affected by chronic kidney disease in developing countries. He also serves on the board for Medical Missions for Children and the Damien Foundation.
Dr. Abdulkareem Alsuwaida, MD, FRCPC, MSc, is the Chief Medical Officer for DaVita in the Kingdom of Saudi Arabia. He is also a professor of medicine at King Saud University School of Medicine and is a Consultant in the Division of Nephrology at the King Khalid University Hospital. Dr. Alsuwaida served as a Chairman for Department of Medicine and was Director of the Post Graduate Educations at King Saud University.
He is also the past President of the Saudi Society of Nephrology. Dr. Alsuwaida received his medical degree from King Abdulaziz University and completed his postgraduate medical education in internal medicine and nephrology at University of Toronto. He received his master’s degree in clinical epidemiology at the University of Toronto.
Dr. Donald Rebhun, MD, MSPH, is the National Medical Director of HealthCare Partners Medical Group and Affiliated Physicians. He is recognized for his work in areas of coordinated care and quality outcomes. Dr. Rebhun is a current Executive Board Member and past Chairman of the Integrated Healthcare Association (IHA) and is presently Co-Chair of the Quality and Performance Committee and Board Member for CAPG-the Voice of Accountable Physician Groups. He is also active in areas of strategic development and is involved with physician and patient education programs, works in areas of legislation and advocacy, and maintains a part-time clinical practice.
Dr. Rebhun is a passionate champion of information technology for patient safety, collaborative treatment decisions, and evidence-based best practices. Dr. Rebhun received his Bachelor of Science, Master of Science in Public Health, and Medical Degree from UCLA. He is board certified in Internal Medicine.
Daniele Rigamonti M.D., F.A.C.S.
Chief Executive Officer, Johns Hopkins Aramco Healthcare
Salisbury Family Professor of Neurosurgery
Professor Department of Neurosurgery
Professor of Oncology, Radiation Oncology and Molecular Sciences
Professor of Radiology
Dr. Rigamonti received his MD degree from the Catholic University in Rome, Italy. He completed his residency in neurosurgery at Mt. Sinai Hospital in New York and trained in neurovascular surgery at the Barrow Neurological Institute in Phoenix, Arizona. In 1987, Dr. Rigamonti moved to Baltimore to join the Division of Neurosurgery at the University of Maryland as an Assistant Professor. He became Associate Professor at University of Maryland before joining the faculty at Johns Hopkins in 1993. At Hopkins he was Director of the Division of Cerebrovascular Surgery from 1993 through 2003.
He became Director of the Radiosurgery and Hydrocephalus Program in 2003 and till he was appointed and Chief Medical Officer at Johns Hopkins Aramco Healthcare (JHAH) in 2015.
In May 2016 he became acting CEO and he was confirmed in this position in November 2016.
His task is to strengthen the company’s health system and establish population health strategies for Saudi Aramco’s 355,000 employees, beneficiaries and retirees.
Dr. Rigamonti’s research clarified the genetics, the MRI appearance, and the natural history of cavernous vascular malformations. His work on spinal epidural abscesses has elucidated the epidemiology, microbiology, and outcome of this often devastating condition. In Radiosurgery, he and his team have analyzed the long-term outcome of radiosurgical management of benign and malignant brain tumors, and provided evidence leading to improved treatment choices.
His work in Hydrocephalus and Pseudo-tumor Cerebri has been impactful and produced considerable improvement in the diagnosis and surgical management, even proving the financial benefit of neurosurgical intervention for these disorders. He was elected President of the International Society of Hydrocephalus and Cerebro-Spinal Fluid diseases in 2016.
Ultimately, Dr. Rigamonti is interested in contributing meaningfully to the development of a new model of Healthcare that is crucial to the delivery of Quality care at a sustainable cost.
Dr. Alain Labrique, PhD, MHS, MS is the founding director of the Johns Hopkins University Global mHealth Initiative, a multi-disciplinary Center of Excellence of over 140 projects engaged in mHealth innovation and research across the Johns Hopkins system. An infectious disease epidemiologist with training in molecular biology and nearly two decades of field experience running large population-based research studies in low and middle-income countries, Dr. Labrique holds joint appointments in the Department of Epidemiology, Bloomberg School of Public Health, the Department of Community-Public Health in the School of Nursing and the Division of Health Informatics at the School of Medicine of the Johns Hopkins University in Baltimore, Maryland. In addition to teaching and training students and faculty at Hopkins and as a Visiting Professor at institutions in Bangladesh and China, Labrique is lead investigator for several research projects measuring the impact of mobile information and communications technologies on improving maternal, neonatal and infant health in resource-limited settings. Dr. Labrique was recognized as one of the Top 11 mHealth Innovators in 2011 by the Rockefeller Foundation and the UN Foundation and was a lead author on a Bellagio Declaration on mHealth Evidence. His work on mHealth strategies for health system strengthening remains among the most cited mHealth resources in the scientific literature.
Dr. Labrique serves as a Digital Health and Technical Advisor to several international and global health agencies and Ministries of Health including the World Health Organization, GSMA, USAID, the mHealth Alliance and HealthEnabled. Dr. Labrique also serves as the current Chair of the WHO mHealth Technical Evidence Review Group (mTERG) and the WHO Digital Health Guidelines Development Group, technical body convened to advise governments on digital health investments. Dr. Labrique received a Presidential Excellence in Advising Award for teaching and mentoring students at the Bloomberg School, as he and his team strive to develop morbidity and mortality reduction strategies for resource-limited settings. Dr. Labrique is also actively engaged in designing and validating diagnostic and public health technologies, and is the inventor of a number of patented diagnostic and anthropometric devices. Dr. Labrique speaks fluent English, French, and Bengali.
Dr. Jeremy D. Walston is the Raymond and Anna Lublin Professor of Geriatric Medicine in the Division of Geriatric Medicine and Gerontology at Johns Hopkins and the Principal Investigator of the Johns Hopkins Older Americans Independence Center (OAIC), which focuses on the development of interventions that may improve health and well-being in older adults. His fellowship in Geriatric Medicine included an intensive laboratory training program focused on the use of basic molecular and genetic approaches to study complex disease. Working with interdisciplinary teams, he helped to identify one of the first gene variants known to contribute to obesity and type 2 diabetes mellitus, helped to develop the most widely used frailty phenotype, and identified and characterize several important biological factors that influence frailty and late life decline.
Most recently, his laboratory and clinical translational research program focuses on the identification of age-related molecular and physiological changes that contribute to frailty and chronic disease states, and on the translation of basic biological findings into clinically relevant interventions. Recent highlights include the identification of an intramitochondrial angiotensin system that changes with age, interventions that target mitochondria and the angiotensin system to slow the trajectory towards functional decline and frailty, and a novel inflammatory index that is highly predictive of mortality and functional decline in older adults.
Dr. Walston has co-authored more than 175 peer-reviewed publications, including publications in the New England Journal of Medicine, the Proceedings of the National Academy of Science, and the Journal of Gerontology. In addition to his role as the PI of the OAIC and several other NIH and foundation awards, he maintains an active clinical practice in Geriatric Medicine, co-directs the Biology of Healthy Aging Program at Johns Hopkins, and is the Deputy Director of the Division of Geriatric Medicine and Gerontology at the Johns Hopkins School of Medicine.
Dr. J. Hunter Young, MD, MHS is an Associate Professor of Medicine and Epidemiology at The Johns Hopkins School of Medicine and the Johns Hopkins Bloomberg School of Public Health, Medical Director for Patient Services at Johns Hopkins Medicine International, Co-Director of the course Clinical Epidemiology and Outcomes Research, and Core Faculty of the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Young’s research program focuses on the genetics and molecular epidemiology of cardiovascular risk factors such as hypertension and diabetes and population-based approaches to the management of these conditions.
In his epidemiologic work, he studies the factors related to the worldwide variation in prevalence of these conditions and the factors related to their poor control. In his program development work, he provides oversight in the development, implementation, and evaluation of novel, population-based approaches to their prevention and management.
Mr. Stephen Nash is the co-leader of the Squire Patton Boggs Healthcare Practice Group. He has represented health care organizations for more than 30 years. His clients include academic medical centers,hospitals and health systems, health information exchanges, medical groups and other physician organizations, health plans and other managed care organizations, long term care organizations, ancillary health service providers, health care investors, state agencies and sovereign powers.
Mr. Nash counsels these organizations regarding governance, corporate,reimbursement, tax, privacy and security, fraud and abuse, and other regulatory compliance issues. These issues typically arise within the context of mergers, acquisitions, joint ventures, corporate reorganizations, complex contractual arrangements and other affiliations and collaborative efforts, as well as in connection with tax-exempt revenue and refunding bond issues.
Recently, Mr. Nash has had the privilege of counseling various domestic and foreign government agencies on such diverse matters as supplemental payment protocols, the design of primary healthcare systems, privacy and security issues, and regulatory requirements for health insurance.
In addition to his transactional and regulatory work, Mr. Nash has over 20 years of experience representing hospitals in single provider and group appeals for Medicare and Medicaid reimbursement, and serves as a strategic advisor on Medicare, Medicaid and private payer matters such as coverage issues and payment methods.
Mr. Nash also has substantial experience representing health information exchanges, including CORHIO, Colorado's statewide health information exchange, which he has advised, since its inception, regarding planning,organization, governance, tax-exemption, financing, contracting, and privacy and security matters. Mr. Nash also represents CIVHC, the administrator of Colorado's state-wide all-payer claims database, or APCD.
Mr. Nash speaks and publishes regularly on topics related to health care law, health information exchanges, corporate governance, clinical integration, collaborative health care ventures and the legal trends influencing the U.S. and foreign health care systems. Mr. Nash earned his B.S, M.B.A. and J.D. from the University of Pittsburg.
Dr. Maha Almozaini is a researcher and scientist. She gained her experience in Immunology and Virology research during her PhD training at the Imperial College School of Medicine, London, UK, and during her post-doctoral research fellowship at the Infectious Disease Division of Massachusetts General Hospital, Harvard Medical School, Boston, USA.
She has already made a substantial contribution to the field of immunocompromised host research and, therefore, established an Immunocomprmised Host research (ICH) Division at King Faisal Specialist Hospital & Research Center (KFSH&RC).
Dr. Almozaini is dedicated to further developing the international collaboration of research that was initiated with MGH, Ragon and Harvard, on both HIV and transplant research. This strategic alliance offers a unique opportunity to perform parallel investigations on immune dysregulation and immune deficiency in patients from two different continents with different genetic background. This will initiate immunological and molecular research collaboration with a true global and international perspective. This cross-cultural contribution will help to better understand immune dysfunction and, as a result, will improve the life quality of patients living with immune deficiency in both countries.
Dr. Almozaini's research is funded by King Abdulaziz City for Science and Technology (KASCT). She is also in the initial steps into developing an HIV awareness programs making her one of the few investigators conducting HIV-1 related research in KSA. Her collaboration with MGH/HMS will allow further understanding of HIV-1 pathogenesis in the Middle East and Arabic Gulf region.
Dr. Khalid S. (Abu) Khabar, is the Deputy Executive Director of the Research Centre at King Faisal Specialist Hospital and Research Centre (KRSHRC) in Saudi Arabia. Director of BioMolecular Research Program and Principal Senior Scientist in the field of molecular biology and immunology. Holds an appointment as Adjunct Staff at the Department of Cancer Biology, Lerner Research Institute and Cleveland Clinic Foundation. Received Ph.D from University of Pittsburgh, 1993. Recipient of the U.S. National Delta Omega Honor, International Cancer Technology Transfer Award from the International Union Against Cancer (UICC) in 2000. Recipient of the first Outstanding Scientist Award in KFSHRC 2002 and several Research Achievement Awards from KFSH&RC. Recipient of the Crown Prince-sponsored Tomorrow Award, 2010 and the King’s award for inventors and talents (2012). Published over 62 peer-reviewed full-length papers including five invited reviews on RNA regulation of cytokines. Principal Investigator on competitive local institutional grants. Co-investigator or Collaborator on a number of international grants including NIH sub-contract. Active reviewer/editor/guest editor for several U.S. and international journals in the cytokine and RNA stability field. Invited for lectures in academic institutions and conference plenary sessions. Member or board member of several national biotechnology development committees. Has more than 20 patents and patent applications in molecular biology.. Expert in molecular cytokine biology, innate immunity, and post-transcriptional control of gene expression.
Mr. Muneer Baig, Founder & CEO of SYSUSA Inc., has over two decades of experience in IT Operations, Governance, Risk Management and Compliance. As a security champion, with in-depth knowledge of technology and business, he serves as a trusted and strategic advisor to information security leadership across diverse group of industries. His strong background in network engineering combined with IT operations and security processes has enabled organizations ensure security, enable innovation and increase collaboration. Mr. Baig has held several positions of responsibility. As an advisor he has enabled transformation of organizations into high performing and secure enterprise.
Prior to venturing into SYSUSA, Mr. Baig enjoyed his tenure at Microsoft where he was part of a three people team responsible for the development and execution of an enterprise wide information security risk assessment program. In a very short time, he became the program owner and was responsible for expanding the program globally. He was also responsible for the development and implementation of an assessor training program to train and certify Microsoft’s information security professionals globally to perform security assessments.
Mr. Baig graduated from Kashmir, India in 1991 and became a very successful business man at a very young age. He travelled to the United States in 1992 to further his dream of entrepreneurship and expand his business. Mr. Baig faced many challenges which resulted in him pursuing a career in IT and contributed to building his knowledge and expertise.
As part of SYSUSA’s leadership team, Mr. Baig is focused on helping organizations create and implement comprehensive Information Security Management Systems (ISMS) where People, Processes and Technologies are aligned to ensure Confidentiality, Integrity and Availability of information assets. SYSUSA’s goal is to ensure that organizations have adequate and effective security controls in place to prevent and deter cyber-attacks.
Mr. Baigis also a graduate of the University of Virginia Sorensen Institute’s Political Leadership Program (PLP) and the University of Virginia Sorensen Institute’s Candidates Training Program (CTP). Mr. Baig's passion for serving his community and his country has led him to serve on several committees and boards, which include:
- Appointment to the Executive Board of Hylton Performing Arts Center
- Appointment to the Board of the Prince William County Department of Social Services
- Appointment to the Board of the Prince William County Zoning and Ordinance Review Committee
- Appointment to the Board of the Prince William County Strategic Transportation Planning Task Force
- Appointment to the Prince William County Human Rights Commission as a Commissioner
- Prince William County Chamber of Commerce Technology Council.
- National Small Business Association Leadership Council
Mr. Baig’s current industry certifications include CRISC, C|CICO, G2700, CPEng, CISM, COM, CISSP, ITIL, ISO 27001 Lead Auditor, ISO 27001 Trainer.
Ms. Deborah Green, MBA, RHIA, is the Executive Vice President and Chief Innovation and Global Services Officer at AHIMA World Congress. She leads AHIMA’s strategic initiatives of Information Governance, Standards and Global Services. Her career has been divided equally across health information management (HIM) and health information technology (HIT). In both areas, she has held leadership positions with large multi-facility, multi-state provider organizations in settings across the delivery system. She served for 10 years as CIO for a large long-term care provider with a presence in 20 states. Since 2013, Deborah has led the multi-stakeholder initiatives to define and advocate for the adoption of Information Governance in healthcare.
She served on the board and as national chairman of AHIMA’s Quality Management Section and was honored with the AHIMA National Visionary Award in 2000. In 2004, she was nominated for the Georgia Woman of the Year in Technology. She has consulted extensively over her career and frequently writes and speaks on health information, healthcare quality, and information governance in healthcare.
Dr. Maan Fares, MD, is a practicing cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, and Vice Chairman of Global Patient Services, at the Cleveland Clinic.
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey.
As a global health care organization with an international reputation for excellence in specialty care particularly in cardiovascular diseases. The department of Global Patients Services helps in organizing the care and management of more than 5,000 patients annually. Patients arrive from all corners of the globe with immensely diverse backgrounds seeking various health care needs. Their care demands excellence in management of complex medical illnesses and special cultural awareness to ensure a better experience and superb outcomes.
Dr. Fares is board-certified in cardiovascular disease, nuclear cardiology/cardiovascular imaging (Level II, including SPECT and PET) and echocardiographic imaging (Level II) and has completed Level II training in cardiac CT angiography. He performs nearly 2,000 nuclear stress tests, 2,000 adult echocardiograms, and more than 2,500 stress tests and EKGs each year.
Dr. Fares earned his medical degree from the University of Damascus, School of Medicine, Syria. He completed a residency at Cleveland Clinic, in Cleveland, Ohio, and a fellowship in cardiovascular medicine at New England Medical Center, in Boston, Massachusetts. Dr. Fares spent time on staff at the Massachusetts General Hospital, Boston, as a clinical associate in echocardiography. Prior to his appointment to the Cleveland Clinic medical staff in 2013, Dr. Fares was a member of the Ohio Permanent Medical Group/Kaiser Permanente medical staff and Chief of Cardiology. Additional positions he held with Kaiser Permanente Ohio include Associate Medical Director for Medical Specialties and member of the Board of Directors.
He is a member of the American College of Cardiology, American Society of Echocardiography and the American Society of Nuclear Cardiology and is a founding member of the Syrian American Medical Society.
Ms. Jennifer Ivory is an expert in business development for the State Department across several major industries. Under the State Department’s healthcare sector, she specialized as Consultant to the State’s ‘Child Diagnostic and Treatment Center’ advising on program development for the center’s youthful patients and residents. During her eight year tenure, Ms. Ivory’s administrative experience ranged from application of legislative policies to conserve patient governmental-healthcare benefits, the overall development and implementation of diagnostic educational recreational and long term treatment programs for the facility’s youthful residential patients.
Ms. Ivory is a 3rd Year Doctoral Candidate (Finance) at Pace University, New York. She received a master's degree-MBA in finance, and a Bachelor's of Science degree in business and urban studies both from St. Peter’s University, New Jersey.
In her capacity as a doctoral candidate Ms. Ivory intends to publish her first quantitative business study in 2017. The conference ready study is entitled: ‘Hegemonistic Growth Thinking From An Endogenous Perspective:Defining The Role Of A Futurist GCC.’ (2017).
Ms. Ivory continues her professional association with the State Department, which she has held since 1995.
Dr. Mohammad Ali Almadani is a consultant of family medicine in the Ministry of Education. He is admitted to the Arab board of Family Medicine.(2003); has his high diploma of Primary Health Care - King Saud University.(2002); and his Bachelor of Medicine and Surgery - Faculty of Medicine - University of King Saud University (1997). He was head of Technical Affairs, General Department of School Health .Director General of School Health (Male ) from 2008 to 2010; Director of the Central Health Unit, Ministry of Education from 2007 to 2009. Also a member of the Anti-Smoking Society in Saudi Arabia; Saudi Society of Family Medicine; Saudi fight against diabetes and the National Committee to combat diabetes. Studying the lifestyle of teachers and students in the Kingdom of Saudi Arabia, with a focus on smoking among primary school teachers in Riyadh; the effect of the weight of school bags to students, Riyadh (2005). He is a contributing author of several books in the field of school health, such as promoting healthy schools. He has prepared and delivered many lectures in the field of School Health. He has also attended many conferences and workshops like the first Gulf Conference for school health in Gulf Arab states (Muscat - Oman - 2007); the eighth scientific meeting of Girls School Health (Abha, 2007); the International Day for diabetes; Seventh Scientific Meeting of the health of school girls under the slogan "health-promoting schools," and, the National Guard International Meeting on "bird flu."
Dr. Nick van Terheyden, Chief Medical Officer at NTT DATA (formerly Dell), brings a distinctive blend of medical practitioner and business strategist, both national and international, to the realm of healthcare technology. A graduate of the Royal Free Hospital School of Medicine, University of London, Dr. van Terheyden is a pioneering creator in the evolution of healthcare technology. After several years as a medical practitioner in London and Australia, he joined an international who's who in healthcare, academia and business, in the development of the first electronic medical record in the early 1990's and later, as a business leader in one of the first speech recognition Internet companies.
His rare combination of patience, creativity, skill and intrinsic business ethics has led him to a diverse career in healthcare with some of the most prestigious hospitals,consulting firms, and technology companies. Previously, he was Chief Medical Information Officer – Clinical Language Understanding for Nuance Communications where his insider perspective allows him to put his medical and technology expertise to work for clients who are striving to raise the bar for healthcare delivery. He is a member of the HIMSS Health Committee where he pays attention not just to processes and systems, but to people. He ofter speaks on the practical and futuristic use of healthcare technology and how it can cost effectively improve patient care.
In addition to writing and lecturing on futuristic trends in healthcare technology, his advice and counsel is sought by hospitals, physicians and other allied healthcare professionals -- all of whom are exploring how to integrate and use technology to make the healthcare system work from the perspectives of quality and financial success.
Osman R. Minkara. M.B.A is the Managing Director of Aldara Medical Corporation. Since its inception, Mr. Minkara played a pivotal role in formulating the business model, securing the necessary assets and partners for the development of Aldara Hospital and Medical Center and leading the executional steps towards the current advanced stage of the project.
In addition, he is the founder and managing principal of CIG Capital Advisors. As Managing Principal, he has been the steward for providing expert business and investment advice for 18 years. Osman’s strategic vision for CIG focuses on: wealth management, asset management, alternative investments and business advisory services. CIG Capital Advisors offers vast experience in dealing with successful aspiring professionals, well-established families and business and their respective owners in pursuit of realizing their dreams.
Osman has served on multiple boards including, Oakland County, Michigan’s Economic Roundtable and The Wayne State University Executive Board. He is currently the Co-Chairman of GenerationOne, Inc. Osman attained a B.S in Finance from Wayne State University, an AMP (Advanced Management Programme) from Oxford and a joint Executive M.B.A. from New York University, London School of Economics and HEC.
In addition, Osman has earned multiple honors including the Excellence in Arab American Business from the Lebanese International Business Council (LIBC) and the “American Arab Professional of the Year Award” for his outstanding accomplishments in Finance from the American Arab Professional Network. Other awards include WSU Emerging Corporate Leader and Detroit Crain’s 40 under 40 (top 40 executives in Michigan under 40 years of age). Over the years, he has become a much sought after thought-leader on Finance subjects and has been interviewed by multiple media channels including ABC and Forbes
Dr. Basmah Al-Buhairan has more than 20 years experience in health care, primarily in leading roles in healthcare delivery. She is currently the Managing Director for Health Care & Life Sciences Sector at SAGIA and, as such, plays a key role in spearheading the Kingdoms efforts to drive new investments across the entire spectrum of the healthcare system in the Kingdom as part of the National Investment Plan. Dr. AlBuhairan leads a team within SAGIA who work closely with the Ministry of Health in implementing their strategy of identifying specific investment opportunities for the private sector within the public health system and reaching out to local and international investors to appraise them of these opportunities and accompany them though the entire investment journey in the Kingdom- ensuring full alignment across all key stakeholders to ensure a seamless investment experience.
Dr. AlBuhairan has held a number of leadership positions in healthcare throughout her career, initially as Director of Laboratory Operations at the Department of Pathology and Laboratory Medicine and subsequently as Assistant Deputy Executive Director of Medical Services at the Ministry of National Guard Health Affairs, King Abdulaziz Medical City in Riyadh. Immediately prior to joining SAGIA, she was the Deputy Chief Executive Officer at King Abdullah bin Abdulaziz University Hospital at Princess Nourahbint Abdulrahman University.
Her achievements transcend international borders as she is a Fellow of the prestigious Eisenhower Fellowships Organization and an Adjunct Assistant Professor at the School of Medicine at the University of Utah. She also serves on the TIGER Initiative Foundation International Committee and the Eisenhower Fellowships Community Board.
Dr. AlBuhairan received her Bachelor of Science in Clinical Laboratory Science from King Saud University in Riyadh, followed by a Master’s degree in Molecular Biology from Brown University in Providence, Rhode Island. Subsequent to that, she received a Master in Public Health and a Doctorate of Philosophy in Public Health and Health Services Research from the University of Sheffield in Sheffield.
Mr. John Payne is Chairman & CEO of PURELIFE Health Sciences Group and heads a team of scientific researchers focusing on genetics and its relation to diabetes. The Arizona and Florida based research group has spent 23 years researching and identifying causes and solutions to metabolic syndrome health issues based on genetics, DNA based nutritional adaptation, and the interactions between genes that are critical to live long & healthy lives. Significant research has been done in Africa and Australia to identify genetically compatible ingestible sources to support broad spectrum human health, taking into consideration xenohormesis, and how it can affect mitochondrial and telomere health, geography, ethnicity and culture. PURELIFE Health Sciences has bio-engineered scientific formulas and clinical protocols that meet the WHO criteria for being genetically compatible, while reducing inflammation and boosting the immune system resulting in prevention of, and long-term reversal of diabetes. They bridge mankind’s ancient, genetically determined DNA with the biological human needs of today. What we eat and drink must match our inherited DNA to be effective in supporting our overall health and wellness. PURELIFE Health Sciences provides the innovative matched resources for health and healthy weight management.
Researcher • Author • Formulator Product / Ingredient Platform Development More than 35 years of experience in developing ingredient platforms for medical and nutraceutical products domestically and internationally. Devoted to developing natural health products that are genetic based and genetically compatible. Concentrating on ingredient profiles that are based on traditional food resources that address the large and growing need for genetic based nutrition.
Nutraceuticals for the prevention and long term reversal of type 2 Diabetes.
Platform for fruit & vegetable extracts for health and Diabetes.
Plant based high viscosity polysaccharides for menopause symptoms.
Nutraceuticals for immune system enhancement.
Pure Minerals for bone, teeth, osteoporosis and dental health.
Plant based weight loss formulas and body composition improvements that work thru the digestive system.
Anti-inflammatory formulas to dampen systemic inflammation.
Plant based insulin resistance formulas for Metabolic Support and Enhancement.
Specific strains of enzymes and critical intestinal bacteria necessary for optimum health.
Identify & develop DNA technologies for genetic based health solutions.
Developed genetically compatible nutritional platforms that effectively prevent and reverse;
- Metabolic Syndrome X diseases c. Insulin Resistance Diseases
AREAS OF EXPERTISE
Technology development – DNA / Genetic based.
Nutritionally changing gene expression formulations.
Health/Marketing need identification.
Infectious disease rapid diagnosis thru DNA testing.
Dr. Lloyd Kolbe, Emeritus Professor at Indiana University School of Public Health, conducts policy research and development to improve the health and education of children and adolescents in the U.S. and other nations. He has held senior positions across private-sector, government, and academic institutions; worked within four presidential administrations; and written more than 160 scientific publications about the health and education of young people. He has served as: Chief of Evaluation for the U.S. Office of Disease Prevention and Health Promotion; Associate Director of the University of Texas Center for Health Promotion Research; Visiting Professor at Beijing Medical University; Member of the U.S. Public Health Service Senior Biomedical Research Service; U.S. Lead for Health Promotion within the U.S.-Russian Joint Commission on Economic and Technological Cooperation; Vice President for Science and Technology of the International Union for Health Promotion and Education; Chairman of the World Health Organization Expert Committee on School Health Promotion; Vice-Chair of the Institute of Medicine Committee on Adolescent Health and Development; and Associate Dean for Global and Community Health at Indiana University. Dr. Kolbe has worked to improve adolescent and school health programs in 28 nations, and served for 18 years as Founding Director of CDC’s Division of Adolescent and School Health, during which his colleagues and he aggregated more than 100 staff and an annual budget of $80 million to systematically improve the health of young people in the U.S.
Dr. Janet Breslin-Smith travels across cultures, both bureaucratic and geo- strategic. As President of Crosswinds International Consulting, she draws on her 30-year career in public service, including leadership roles in the United States Senate, the National War College, and in Saudi Arabia, where she focused on higher education and outreach to women in the Middle East. She has written and lectured on strategy and culture, macro-economics and Islam, Women, Islam and Saudi Arabia. Her article, “The Struggle to Erase Saudi Extremism” appeared in November 2015 in the New York Times. She is the co-author of The National War College: A History of Strategic Thinking in Peace and War.
Dr. Breslin-Smith, a Professor of National Security Strategy for 14 years at the National War College in Washington, DC, was the first woman to Chair the Department of National Security Strategy. She was named Outstanding Professor at the College in 2006. Prior to her academic career, she was Legislative Director for Senator Patrick J. Leahy and Deputy Staff Director of the Senate Agriculture Committee.
She resided in Riyadh, Saudi Arabia from 2009 through 2013, with her husband, Ambassador James Smith. Dr. Breslin-Smith developed extensive contacts with Saudi women leaders in higher education, medicine, business, banking, philanthropy, sports, and on-line entrepreneurship. She lectured at al Faisal University, the Diplomatic Studies Institute, and CellA+ women’s business networks. She consulted with Saudi women members newly appointed to the Shoura Council.
Dr. Breslin-Smith earned her Ph.D. from the University of California at Los
Angeles and her undergraduate degree in International Relations from the
University of Southern California.
Ms. Randa El-Sayed Haffar is an AUB trustee since 2011 and an AUB graduate (BA ’90). She previously worked for the Private Bank of Chase Manhattan Bank, Coutts Bank, and the Bank of New York. Ms. El-Sayed Haffar has been a director of the Elmer and Mamdouha Bobst Foundation since 2008 and has been involved in the Worldwide Alumni Association of AUB (WAAAUB) as a member-at-large and a member of its Strategic Planning Task Force. She is a past vice president of the New York Metropolitan Chapter of the AUB Alumni Association of North America and a graduate of New York University (MPA ’95).
Mr. Zaher ("Z") El-Assi serves as Vice President of Sales Transformation for IBM Watson Health, defining the new way Watson Health goes to market. He has been with IBM or IBM-acquired assets for a decade. Previously, he served as President of Merge Healthcare’s eClinical division, where he led the creation of Merge eClinicalOS, a cloud-based data capture and management solution for the clinical trial industry.
Prior to joining Merge Healthcare, Mr. Zaher served as the Vice President of Global Sales & Strategic Partnerships for Boston-based Kika Clinical Solutions. With Kika, Mr. Zaher was responsible for establishing and developing international partnerships and building upon their diverse client base. He is credited for leading the successful sale of Kika Clinical Solutions to Merge Healthcare in 2010.
Dr. Wael Kaawach completed his Bachelor of Medical Biology with First Class Honors followed by his Medical Degree at The University of Aberdeen in Scotland. Dr. Kaawach then finished his residency and fellowship at the Harvard University Orthopedic Surgery Program. After which he joined The Harvard Medical School Faculty as an Instructor and Consultant in Orthopedic Surgery, and later appointed as the Chief of Orthopaedic Surgery at the Boston VA Healthcare System. He earned a Commendation Award from the US Department of Veteran Affairs and has multiple publications in peer-reviewed journals.
While in Boston, he managed to obtain an MBA in Healthcare Management; during which and upon his return to Jeddah, he was a cofounder, Board Member and Chief Medical Officer of the International Medical Center (IMC). He was instrumental in many aspects of the IMC's development, partnerships and staff recruitment.
Currently, he is the CEO of The Healthcare Development Holding Company (HDH), the healthcare arm of the Saudi Binladen Group. Since the inception of HDH in 2008, he has developed eleven subsidiary companies and five international affiliations that are specialized in various healthcare focused businesses with projects in Saudi Arabia and the region. It also has an affiliation with Cleveland Clinic Foundation, Ohio, USA (CCF) that resulted in the first Cleveland Clinic Global Solutions (CCGS) office in Riyadh, Saudi Arabia
Ms. Paula Wilson is President and Chief Executive Officer of Joint Commission Resources (JCR) and its international division, Joint Commission International (JCI). JCR and JCI are not-for-profit organizations working to improve health care quality and patient safety in nearly 90 countries around the world. JCI is leading health care improvement worldwide through its work with The Joint Commission as a WHO Collaborating Centre for Patient Safety Solutions, through development of international standards for quality and safety and international patient safety goals, and by offering domestic and international consulting, international accreditation, education, publications, Continuous Service Readiness, and e-Learning.
Ms. Wilson has more than 30 years of experience in the health care industry. Most recently, she provided management and strategic planning expertise as a consultant to public, nonprofit and private organizations. She was previously the vice president for policy at the United Hospital Fund, leading efforts to shape public policy changes related to insurance coverage, health care financing and Medicaid. Early in her distinguished career, Ms. Wilson served in several senior positions in the administration of New York Governor Mario Cuomo, including the executive deputy commissioner of the New York State Department of Health, and was responsible for all operational and management activities of a $1.2 billion organization with 7,000 employees. She also served as deputy director of the New York Division of the Budget, and as a program associate for Health and Human Services on the governor's staff.
Ms. Wilson taught courses in financial management and public and nonprofit administration at Columbia University School of International and Public Affairs, and graduate courses in health care financial management and corporate compliance at the Wagner School of Public Service at New York University.
Ms. Wilson received her master's degree in social work from the State University of New York at Albany. She is a member of the Board of the New York City Health and Hospitals Corporation and serves on the finance committee of the Saint Mary's Center, Inc., a nursing home for people with AIDS.
Mr. Muhammad Shazlee is the Chief Technology Officer at SYSUSA Inc. He has more than 18 years’ experience of leadership, design, development and implementation of complex Information Technology solutions, and Program Management.
Before joining SYSUSA, Mr. Shazlee served as the Senior Director of Technology at Challenger Center.
He has a proven track record of managing teams and projects from concept to delivery within time frame and budget. He is well versed in systems architect, project management, systems administration, network engineering, databases and enterprise level hardware.
Mr. Shazlee is a business thought leader, with emphasis on services, business functions, support, quality, standards and best practices.
Dr. Philip A. DeFina, PHD, as Chief Executive Officer and Chief Scientific Officer of the International Brain Research Foundation (IBRF), spearheads the collaborations among top neuroscientists and research facilities around the world by facilitating and coordinating cutting-edge research. Under his leadership, IBRF is in a position to accelerate the scientific findings that are key to solving the complex issues in the area of brain health.
Dr. DeFina is a well-known author, lecturer, and clinician. He was a guest researcher at the National Institutes of Health and was a member of the international neuroscience subcommittee of The World Health Organization. He has been a pioneer in developing and directing national clinical training programs in the cognitive neurosciences. His numerous collaborative efforts with prestigious research centers throughout the world have evolved into the creation of the framework which led to the formation of the IBRF.
Dr. Prestigiacomo, as Chairman and Director of the Neurological Surgery Residency Program, leads the Department of Neurological Surgery at New Jersey Medical School. He also directs the Cerebrovascular Center in the Department of Neurological Surgery at the The University Hospital.
Dr. Prestigiacomo is renowned for his specialty in cerebrovascular microsurgery (aneurysms, AVM, cavernous malformation, carotid endarterectomy and bypass), endovascular surgery for the treatment of all brain, spinal cord and head/neck pathology (aneurysms, AVM, stroke, tumor, vessel occlusion) and stereotactic radiosurgery for vascular lesions. His research has included topics such as the outcomes in subarachnoid hemorrhage, mechanisms of cerebral vasospasm, decision analysis and biophysics of aneurysm formation.
During his residency, Dr. Prestigiacomo became interested in the various aspects of cerebrovascular disease. This interest led him to spend one year on the Interventional Neuroradiology/Endovascular Service at Columbia-Presbyterian, studying the numerous techniques by which cerebrovascular disease could be treated from within the vessels of the brain and spinal cord.
After completing his residency in 2000, Dr. Prestigiacomo sought further subspecialized training in Neurointerventional Radiology/Endovascular Surgery at Beth Israel Medical Center. During this time, he continued to develop the necessary endovascular skills for the treatment of diseases of the brain and spinal cord as well as the head and neck.
Dr. Machado is President of the International Symposium on Brain Death and Disorders of Consciousness, President of the Cuban Society of Neurophysiology, and Senior Professor and Researcher at the Institute of Neurology and Neurosurgery, Havana, Cuba. Dr. Machado has spent over 20 years devoted to the topic of brain death and altered consciousness, authoring dozens of scientific papers and books, including most recently Brain Death: A Reappraisal - Dr. Machado collaborates only to confirm diagnoses of brain death OR other states of disorders of consciousness.
Dr. Paul Grundy, MD, MPH, FACOEM, FACPM is chief medical officer and global director of healthcare transformation for IBM's Healthcare and Life Science Industry. In this role, he develops and executes strategies that support IBM’s transformation initiatives in the healthcare industry. Dr. Grundy is also a healthcare ambassador for the nation of Denmark and an adjunct professor at the University of Utah Department of Family and Preventive Medicine. He is a member of National Academy of Medicine; director of the ACGME, the body responsible for accrediting graduate medical training programs; and a member of the national advisory board to the National Center for Interprofessional Practice & Education.
Dr. Grundy is the founding president of the Patient-Centered Primary Care
Collaborative (PCPCC) where he served as president of its Board of Directors
from 2006 through January of 2016. The PCPCC is a not-for-profit membership
organization dedicated to advancing an effective and efficient health system
built on a strong foundation of primary care and the patient-centered medical
home. Dr. Grundy was made an honorary member of the American Academy of Family
Physicians in 2008 and the first international honorary member of the Irish
National Association of General Practitioners. He is a retired senior diplomat
with the rank of minister consular at the U.S. State Department.
Dr. David Lane, Ph.D. is the Systemwide Deputy Compliance Officer for the University of California, working out of the Office of Ethics, Compliance, and Audit Services. Located in the Regental office of the Senior Vice President, his duties include working with campuses on developing their risk assessments and annual compliance plan, overseeing healthcare compliance with the five University of California academic medical centers and medical schools, monitoring research compliance programs for the University, and managing the University’s Policy Office and privacy program.
Prior to coming to the University of California, Dr. Lane worked for eight years with the Hawaii Health Systems Corporation (HHSC), the United States’ fourth largest public hospital system where he was the Chief Compliance and Privacy Officer. He has served in various compliance roles as bureau director for the City of Portland, Oregon, the Oregon Health Division, and the Hawaii Department of Health.
Dr. Lane was on the faculty of The Oklahoma State University and the Missouri State University. He also worked in the Office of Personnel and Faculty Relations for the Board of Regents in the State University System of Florida. He earned his doctorate in educational psychology from The Florida State University and a Bachelors Degree from St. Olaf College. Dr. Lane has presented at numerous national healthcare compliance conferences and recently spoke at the European Compliance Institute.
Dr. Rashed Al-Kawan is the Assistant Deputy Minister for Transformation at the Ministry of Health (MOH). Previous to this, Dr. Al-Kawan served as a senior consultant for transformation at the MOH and as a senior consultant in the private sector. He was also the Associate CEO for King Faisal Specialist Hospital and Research Center in Jeddah. Dr. Al-Kawan is a member of the Canadian College of Family Physicians and the American Board of Anti-Aging, and has a master’s degree in medical management from Carnegie Mellon. He also has a certification in medical management from the American College of Executive Physicians.
Mr. Hisham Radwan is the regional general manager of Aetna International, Middle East and Africa. Based in Aetna’s Dubai offices, he joined Aetna in 2013 and leads a strong multi-cultural team of nearly 200 people. He is also responsible for expanding Aetna’s international business in the region.
Mf. Radwan works closely with Aetna’s strategic partners, governments and health officials to provide empowering health management solutions in MEA.
Mr. Radwan has a strong track record of driving profitable growth and maximizing business efficiencies in the health care benefits industry in the Middle East. Under his leadership, Aetna’s MEA business has achieved two fold increase in membership and revenue, significantly improved customer service, medical cost management discipline, and firm foundations for sustained future profitable growth.
Before joining Aetna, he worked for 20 years for the Nazer Group in Saudi Arabia, where he launched Bupa Arabia IPO on the Saudi Stock Exchange (Tadawul) and grew the company from a start up to over 1.3 million customers. In 2002, he was a member of the team that set up Bupa International Egypt and continued as a board member until joining Aetna.
During his tenure in Saudi Arabia, Mr. Radwan was also an active member of the insurance regulatory and supervisory sub-committees of the Saudi Arabia Monetary Agency (SAMA) and CCHI as a representative of the private insurance companies.
Dr. Mohammad JA Al Ghamdi, MD, CCFP, MBA, CPHQ is Director of Population Health at Johns Hopkins Aramco Healthcare. He joined Saudi Aramco Physician Training Program in June 1998. After spending one year, he was sponsored to complete his residency program in Family Medicine at University of Toronto in 1999. From 2002 to 2011, Dr. Ghamdi held several leadership positions in Primary care including the Chief of Primary care at Dhahran, Al Hasa, and Abqaiq. During this time, he was part of developing several health prevention programs including TB screening and cancer prevention programs. He also helped in the development of health registries which included a diabetes registry.
He also worked on the implementation of electronic health record system for
Saudi Aramco and worked on several projects to modify those systems to fit
patient care needs. In 2011, he join the Medical Care Management Department and
became the chief of the eastern region working with most of the private
hospitals in the eastern region to deliver better care of Saudi Aramco's
population. During this time he completed his degree in business administration
with honors and become certified in health care quality. In 2016, Dr. Ghamdi
completed his fellowship in Palliative Care. Then, in August of 2016, Dr. Ghamdi
joined the Population Health Department where he is working now in the capacity
of Director for Population Health, in addition to co-leading the palliative care
program at JHAH.
Dr. Nashat Nafouri is Chairman & Executive Officer of the healthcare group for the Saudi Quality Council Board in KSA. An advocate in Health Care Excellence models, Safety, Occupational Health, Infections Prevention and Environmental Health, he has over 20 years of experience. He is the Ambassador of the Program Office for Laboratory Quality Management of the University of British Columbia, Canada and regional representative of the Clinical Laboratory Management Association (CLMA), USA. Dr. Nafouri is a lecturer in the Community Medicine Saudi Board. He is editorial board member in safety in health journal and Patient Safety Lecturer at King Saud Bin Abdulaziz University for Health Sciences. He is a part time faculty member of the American University of Cairo (AUC).
Dr. Nafouri is an appointed Consultant by the Saudi Standards, Metrology and Quality Organization (SASO) to assess the health sector readiness based on King Abdulaziz Quality Award Standards as foundation to structure the 2020 National Quality Strategy. He Led assessment teams in Abu Dhabi Award for Excellence in Government Performance in 2008 and led Taif Award teams in 2009, 2010, 2014 and 2015. He is an Assessor in the 2015 Abu Dhabi Award for Excellence in Government Performance and registered Assessor at King Abdulaziz Quality Award and participated in the 2nd cycle. He is the Facility Management and Safety Chapter Leader and Quality Observer towards the Joint Commission International Accreditation (JIC) at King Abdulaziz Medical City (KAMC) –Jeddah, Health Affairs, Ministry of National Guard from 2014 – 2016. He was Co-leader of Prevention and Control of Infection chapter of the 2ndJCI re-accreditation. He is registered inspector with the Collage of American Pathologists and active member of the Emergency Preparedness and many healthcare Commissioning Committees at KAMC-Jeddah. Dr. Nafouri is the founder of Quality Logic and the Seeding Knowledge Conference series. He is an Advisory Board member of the Middle East Quality and Patient Safety Conference Series since 2012.
Dr. Nafouri is the 2015 Quality Leadership Award winner endorsed by the World Quality Congress and Awards and Asian Confederation of Business. He has many publications and instrumental researches and workshops that are searchable on the internet.
Mr. Lieven Jacquemyn is the International PPP Development Director of GE Healthcare. He joined the company in 2016 and is part of the Strategic Partnerships Center of Excellence. Mr. Jacquemyn is based in Singapore and responsible for identifying and structuring Public Private Partnerships (PPP) and Managed Equipment Services (MES) deals globally. Previously He advised the Emaar Economic City on the procurement of their High-end polyclinic in the King Abdullah Economic City and currently he is involved in structuring various PPP/MES projects in Saudi Arabia and UAE.
Prior to joining GE Healthcare, Mr. Jacquemyn worked as project manager and investor in Healthcare and Education PPP projects across Europe and Asia. He was also a financial advisor to private investors and governments successfully structuring bankable infrastructure PPP in Transportation and Renewable Energy projects.
Mr. Jacquemyn holds an MBA degree in International Business from the Grenoble Ecole de Management and a Master’s degree in Architectural Engineering from the University of Leuven.
Dr. Sneh Khemka, MBChB, MRCOphth (Hon), MFPH, is the current President of International Population Health Solutions (IPHS) at Aetna International. In this position, he is responsible for managing and growing a strategically important business within Aetna Inc.
Aetna Inc is one of the largest healthcare companies in the United States (2013 turnover of US$ 47 billion), and IPHS is one of its fastest growing arms. IPHS is positioned to help governments and large organisations manage the health of their populations better, primarily through infrastructure development (major IT systems), clinical data analytics, health & disease management, and ultimately primary care.
Having trained as a surgeon, Dr. Khemka went on to successfully establish and sell his own business. He then joined the Bupa Group and was promoted through a variety of pivotal roles in the company, including Medical Director and Director of Healthcare Development. Subsequently, he was Chief Operating Officer of Advanced Oncotherapy plc, a spin-off from CERN (home of the Large Hadron Collider).
Dr. Khemka was formally a non-executive director of the Joint Commission International, the leading hospital accreditation authority and he has also advised and acted for a number of private equity houses in the UK and Europe.
In his spare time, he works as a radio doctor (with a weekly show on LBC), an expedition doctor and is on the board of a major UK charity.
Dr. Ahmad Balkhair is Director General of the National Health Information Center. He is considered an accomplished thought leader in the eHealth domain. Combining the skills and knowledge of the clinical and business side, along with the technical expertise and know-how, he has held many key positions in the Kingdom's healthcare system. Coupled with a strong leadership style and managerial skills, demonstrated through successful large-scale transformation endeavors over the past years, his achievements have included:
- Health Care Leader, Senior Consultant – Global Business Service. IBM, KSA. May 2016 – Nov 2016
- Advisor to the General Director of Makah Region Health Affaires. Feb 2015-April 2016
- Director of the National eHealth Strategy and Change Management Office – ICT, MOH. March 2010-Feb 2015
- Chair of IHE Saudi. 2013- present
- Board member of the IHE International. 2013 - present
- Board Member in the Saudi Pediatric Association. 2012 - present
- Lead the development of the Saudi National EHealth strategy 2010.
- Supervise the initiative of the development of the Health Information Exchange Policy and Standard.
- Represent Saudi Arabia in WHO for the interoperability standard and EHealth strategy meetings.
- Lead the development of the Saudi Telemedicine roadmap.
- Lead the development of many EHealth strategic initiatives and projects such as:
• Health information system for the hospitals and primary health care centres for all MOH facilities (RFP).
• Establishment of the Strategy and Change Management Office.
• The development of the Health Information Exchange Standard and Policy Project.
• The diagnostic imaging repository and tele-radiology services.
• Saudi EHealth Information Exchange Engine SeHE Project.
• The foundational project for the Tele-Medicine Services Project
Dr. Nahar is Chief Medical Officer, Aldara Hospital & Medical Center. Dr. AlAzemi brings to AHMC more than 22 years experience in hospital operations and clinical practice. A family physician for nineteen (19) years, Dr. Al Azemi is well qualified for his role as Chief Medical Officer at AHMC. He earned his MBBS at King Saud University and later achieved a Diploma in Child Health from the Royal College of Surgeons, Ireland and an Executive Master of Healthcare Administration (EMHA) from Washington University, St. Louis, USA. Dr. Nahar also attained Saudi Board registration in Family Medicine (SBFM) as well as the Arab Board in Family Medicine (ABFM).
During his distinguished career, Dr. Al Azemi has served in several leadership roles. He was the inaugural CEO of Prince Mohammed Medical City (PMMC), a major healthcare project in the Northern region. He played a leading role in the commissioning and operation of King Fahad Medical City (KFMC) in Riyadh where he later became Executive Director of Medical Affairs, Executive Director of Academic & Training Affairs and Continuous Professional Education. Dr. Al Azemi has also served on the Board of Directors of the Medical Cities and Specialized Hospitals, under the chairmanship of H.E. Minister of Health.
He was also a former Assistant Deputy Minister for Hospital Affairs at The Ministry of Health, KSA. Dr. Al Azemi has a broad and invaluable perspective on healthcare including healthcare strategy, planning, commissioning and operations.
Achievements, Awards and Recognitions:
- Participated in the formation of KFMC Master Plan for future expansion
- Established the Emergency and Employee Health Administration at KFMC
- Led the Organizing Team for launching the KSA-USA Partnership in Breast Cancer screening campaign
- Led the patient-centered care chapter for JCIA, CBAHI accreditation at KFMC
- Established the Homecare Unit in Tabuk’s North-West Armed Forces Hospital
- Established the first School of Nursing in the Northern Region
Engr. Walid Basoudan brings 28 years of experience in the Health, Energy, Power and manufacturing industry. He started his career in1987 as a Mechanical Engineer in Saudi Aramco. After Aramco, Eng. Walid worked as a Senior Project Engineer at Saline Water Conversion Corporation. In 2003 he became the Privatization Program Managing Director and Vice Chairman of Strategic Planning where he lead the privatization, restructuring, planning and change management program in Saline water Conversion Corporation. During his career in 2005, he worked as Vice President for Tendering & Business Development in EL Seif Engineering Contracting Company, where he lead the construction for power generation, airport projects, railways, civil works. In 2007 Mr. Walid Basoudan worked as a Member of the Board of directors at Saudi Masader for Water & Power Company where he also held the title of President & CEO. In this position he had a broad portfolio of assignments ranging from investments in projects for the power and water sectors. He also lead numerous financing, mergers , acquisitions and the development of new projects in the water & power sector. In February of 2012 Mr Walid Basoudan worked as the Executive Vice President of Al-Ayuni Investment & Contracting Co. and held a position of Board member for the following Companies:
- Sedelmy Power (Italy)
- Siraga (France)
- Equipment's & Trucks Co. (K.S.A)
- Saudi Masader (K.S.A)
He was responsible for handling of business development outside the Kingdom of Saudi Arabia; and he negotiated and acquired various companies from all over the world: USA, France, Italy, India, Brazil, Africa & Bangladesh. In August of 2013 , he became CEO of Al-Saghyir Trading & Contracting Company which is in the field of buildings and construction as well as a leading company in the trading and industrial market. He was responsible for managing four sectors:
- Construction Sector
- Building Materials
- Boilers & Pressure Vessels factory 4- Laundry Equipments
- Office Furniture
In May of 2016, Eng. Walid Basoudan started working as the Private Sector Participation Theme Director for Health Strategic Transformation Center, handling all initiatives that have been approved by the Delivery unit.
Mr. Arjen Radder was appointed as Chief Executive Officer Middle East & Turkey on 01 February 2015. He is responsible for all Philips business in the geography. He joins the Middle East & Turkey Market from Asia where he was the President for Philips Healthcare in Asia Pacific, covering India, Japan, Korea, Australia New Zealand and ASEAN. During this time he was also a member of the Philips Healthcare Global Executive Team.
His career in Philips began as Managing Director Netherlands for an early Home Healthcare venture. Subsequently, he worked as General Manager at the Nuclear Medicine business based out of California, USA. Later on he assumed the role of Market Leader for Nordic Healthcare and became Senior Vice President/Market Group Leader for Central & Eastern Europe, Middle East & Turkey, Russia & Central Asia and Africa early 2010. Before Philips, he held leadership roles at a number of other companies including his role as General Manager at Nutricia’s (now Danone) clinical division.
Mr. Radder was fortunate to work in 3 distinct time zones, at small companies and MNCs and experience both commercial as well as innovation challenges. He was born in Amsterdam, the Netherlands and obtained a PhD in Medicine prior to joining the healthcare industry in the mid-nineties. Mr. Radder is married and with two sons and enjoys participating in half and full marathons.
Professor Adnan Ezzat is the Chief Executive Officer (CEO) of Aldara Hospital and Medical Center, an international primary and secondary care organization working with the Henry Ford Hospital, Detroit. He is also Professor of Oncology at the College of Medicine of AlFaisal University
Professor Ezzat has had a long and distinguished career in Medicine and international healthcare. Achieving his MDCh in 1978, he obtained double-board certification in Internal Medicine and Medical Oncology in Canada and the United States. He was appointed as a Consultant Medical Oncologist in 1988 and by 2000, had become Chairman of the Department of Oncology at King Faisal Specialist Hospital.
Under his leadership, the King Faisal Specialist Hospital & Research Center’s (KFSH&RC) Oncology Centre was established in 2001 and was recognized as a World Health Organization (WHO) Collaborating Centre for Oncology. Professor Ezzat remained as Chairman of the Department until 2005. Also in 2005, Professor Ezzat received the honor of being appointed by Royal Decree to the Board of Directors of King Faisal Specialist Hospital & Research Centre, for a period of three years. His other roles as Executive Director for Medical & Clinical Affairs at KFSH&RC and as CEO of the Dr. Suleiman Fakeeh Hospital means that he brings invaluable clinical, operational and strategic perspectives to healthcare. In 2009 he achieved the MBA from the Frankfurt School of Finance & Management.
Deeply committed to the practice of Oncology and related sub-specialties, Professor Ezzat was actively involved in establishing a WHO endorsed Palliative Care fellowship program for physicians in the Eastern Mediterranean region. His work has been acknowledged in the Who’s Who in Medicine and the Barons 500. He has also been a highly sought after regional representative on several WHO panels.
As well as being a highly accomplished physician, leader and CEO Professor Ezzat is also a prolific researcher, writer and presenter. His achievements in this area include membership of many editorial boards including of the Lancet (Middle East), the Annals of Saudi Medicine, the Pan Arab Oncology Newsletter and Hematology/ Oncology and Stem Cell Therapy. In addition, Professor Ezzat has participated in over 91 Research Advisory Council approved projects; produced 5 book chapters, two book reviews and 127 manuscripts in peer reviewed journals. He has had an impressive 175 abstracts published or presented.
Finally, it is no surprise that for a professional of his caliber, Professor Ezzat has received or been nominated for prestigious recognitions and awards including the Arab-American Cancer Foundation’s Distinguished Recognition Award and Honorable Recognition on the KFSH&RC Honor Board for distinguished contribution.
Mr. Louai Alzaher is the Deputy Head of Project & Structured Finance at Arab National Bank. He has over 17 years of progressive commercial and investment banking experience. In his current role, Mr. Alzaher is responsible for originating, negotiating, structuring, and executing project and structured finance transactions. He successfully completed several large transactions in sectors that included infrastructure, power and water (IPPs/IWPPs), petrochemicals, and mining. Before assuming his current role, he worked as an investment banker advising on equity capital market and M&A transactions, and prior to that in corporate banking.
Mr. Alzaher holds a Master of Business Administration in Finance degree from Leicester University.
Alain is a partner who is based in the Riyadh office. He has seventeen years' experience in the Middle East with over eleven of them in the Saudi market specialising in all aspects of corporate matters including foreign direct investments, mergers and acquisitions, corporate restructurings, joint ventures, and investment funds. Alain also advises on corporate finance matters including securities and capital markets and he has handled more than 14 capital market transactions including IPOs, rights issue and private placements involving leading groups in Saudi Arabia.
Alain advises clients of all business sizes from small and medium size institutions to multinational corporations providing them with a comprehensive full legal service. He has also assisted a large number of clients across all industries in connection with setting up and franchising their business in Saudi Arabia.
Ms. Haifa graduated from King Saud University department of laboratory sciences. Later she worked at King Faisal Specialist Hospital and Research Center 13 years after completing a training in cytopathology at Mayo School of Health related sciences in Mayo Clinic Hospital Rochester MN.
Ms. Haifa held several positions in the cytology laboratory including being a supervisor of cytopathology laboratory before moving to the Ministry of Labor in 2014. She is a member of the International Institute of Internal Auditors and the American Society of Clinical Pathology and the International Academy of Cytology.